A Novel Method for Conjugating the Terminal Amine of Peptide Ligands to Cholesterol: Synthesis iRGD-cholesterol

References

• Fukumori Y Ichikawa H . Nanoparticles for cancer therapy and diagnosis . Adv. Powder Tech.17 ( 1 ), 1 – 28 ( 2006 ).
   Web of Science ®Google Scholar
• Kaneda Y Tabata Y . Non-viral vectors for cancer therapy . Cancer Sci.97 ( 5 ), 348 – 354 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Li SD Huang L . Gene therapy progress and prospects: non-viral gene therapy by systemic delivery . Gene Ther.13 ( 18 ), 1313 – 1319 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Wilhelm S Tavares AJ Dai Q et al. Analysis of nanoparticle delivery to tumours . Nature Rev.1 ( May 2016 ), 1 – 12 ( 2016 ).
   Google Scholar
• Hobbs SK Monsky WL Yuan F et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment . Proc. Natl Acad. Sci. USA95 ( 8 ), 4607 – 4612 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Maeda H Nakamura H Fang J . The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo . Adv. Drug Del. Rev.65 ( 1 ), 71 – 79 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Matsumura Y Maeda H . A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS . Cancer Res.46 ( 12 Pt 1 ), 6387 – 6392 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Wu NZ Da D Rudoll TL Needham D Whorton AR Dewhirst MW . Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor-tissue . Cancer Res.53 ( 16 ), 3765 – 3770 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Blank N Laskov I Kessous R et al. Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin . Cancer Chemoth. Pharm.80 ( 4 ), 737 – 743 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Feldman EJ Kolitz JE Trang JM et al. Pharmacokinetics of cpx-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:Daunorubicin, in patients with advanced leukemia . Leukemia Res.36 ( 10 ), 1283 – 1289 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lancet JE Cortes JE Hogge DE et al. Phase 2 trial of cpx-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML . Blood123 ( 21 ), 3239 – 3246 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Olivieri J Perna GP Bocci C et al. Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin . Oncologist22 ( 4 ), 422 – 431 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Petersen GH Alzghari SK Chee W Sankari SS La-Beck NM . Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin . J. Control. Rel.232 , 255 – 264 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bae YH Park K . Targeted drug delivery to tumors: myths, reality and possibility . J. Control. Rel.153 ( 3 ), 198 – 205 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kirpotin DB Drummond DC Shao Y et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models . Cancer Res.66 ( 13 ), 6732 – 6740 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Kwon IK Lee SC Han B Park K . Analysis on the current status of targeted drug delivery to tumors . J. Control. Rel.164 ( 2 ), 108 – 114 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Aleku M Fisch G Mopert K et al. Intracellular localization of lipoplexed siRNA in vascular endothelial cells of different mouse tissues . Microvascular Res.76 ( 1 ), 31 – 41 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Santel A Aleku M Keil O et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium . Gene Ther.13 ( 16 ), 1222 – 1234 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Thurston G Mclean JW Rizen M et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice . J. Clin. Invest.101 ( 7 ), 1401 – 1413 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Nie X Zhang JK Xu Q et al. Targeting peptide iRGD-conjugated amphiphilic chitosan-co-PLA/DPPE drug delivery system for enhanced tumor therapy . J. Mater. Chem. B2 ( 21 ), 3232 – 3242 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sugahara KN Teesalu T Karmali PP et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors . Cancer Cell16 ( 6 ), 510 – 520 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Sugahara KN Teesalu T Karmali PP et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs . Science328 ( 5981 ), 1031 – 1035 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Teesalu T Sugahara KN Kotamraju VR Ruoslahti E . C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration . Proc. Natl Acad. Sci. USA106 ( 38 ), 16157 – 16162 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Mirshafiee V Mahmoudi M Lou KY Cheng JJ Kraft ML . Protein corona significantly reduces active targeting yield . Chemical Comm.49 ( 25 ), 2557 – 2559 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Salvati A Pitek AS Monopoli MP et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface . Nat. Nanotechnol.8 ( 2 ), 137 – 143 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Xu L Betker J Yin H Anchordoquy TJ . Ligands located within a cholesterol domain enhance gene delivery to the target tissue . J. Control. Rel.160 ( 1 ), 57 – 63 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Verhoef JJF Anchordoquy TJ . Questioning the use of pegylation for drug delivery . Drug Deliv. Transl. Res.3 ( 6 ), 499 – 503 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Verhoef JJF Carpenter JF Anchordoquy TJ Schellekens H . Potential induction of anti-peg antibodies and complement activation toward pegylated therapeutics . Drug Discov. Today19 ( 12 ), 1945 – 1952 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Xu L Anchordoquy T . Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics . J. Pharm. Sci.100 ( 1 ), 38 – 52 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ganson NJ Povsic TJ Sullenger BA et al. Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a pegylated rna aptamer . J. Allergy Clin. Immunol.137 ( 5 ), 1610 – 1613 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Povsic TJ Lawrence MG Lincoff AM et al. Pre-existing anti-peg antibodies are associated with severe immediate allergic reactions to pegnivacogin, a pegylated aptamer . J. Allergy Clin. Immunol.138 ( 6 ), 1712 – 1715 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Banerjee R Tyagi P Li S Huang L . Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells . Int. J. Cancer112 ( 4 ), 693 – 700 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Guo JF Darcy R O'driscoll C . Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery in cancer cells: physicochemical characterisation and in vitro evaluation . Human Gene Therapy19 ( 10 ), 1160 – 1160 ( 2008 ).
   Web of Science ®Google Scholar
• Laakkonen P Porkka K Hoffman JA Ruoslahti E . A tumor-homing peptide with a targeting specificity related to lymphatic vessels . Nature Med.8 ( 7 ), 751 – 755 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Li SD Huang L . Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells . Mol. Pharm.3 ( 5 ), 579 – 588 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Betker JL Kullberg M Gomez J Anchordoquy TJ . Cholesterol domains enhance transfection . Ther. Deliv.4 ( 4 ), 453 – 462 ( 2013 ).
   PubMedGoogle Scholar
• Xu L Anchordoquy TJ . Cholesterol domains in cationic lipid/DNA complexes improve transfection . Biochim. Biophys. Acta1778 ( 10 ), 2177 – 2181 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y Anchordoquy TJ . The role of lipid charge density in the serum stability of cationic lipid/DNA complexes . Biochim. Biophys. Acta1663 ( 1–2 ), 143 – 157 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y Bradshaw-Pierce EL Delille A Gustafson DL Anchordoquy TJ . In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation . J. Pharm. Sci.97 ( 1 ), 237 – 250 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Xu L Anchordoquy TJ . Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells . Mol. Pharm.7 ( 4 ), 1311 – 1317 ( 2010 ).
   PubMedGoogle Scholar
• Betker JL Anchordoquy TJ . Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro..Mol. Pharm.12 ( 1 ), 264 – 273 ( 2015 ).
   PubMedGoogle Scholar
• Watcharanurak K Nishikawa M Takahashi Y Takakura Y . Controlling the kinetics of interferon transgene expression for improved gene therapy . J. Drug Target.20 ( 9 ), 764 – 769 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Betker JL Anchordoquy TJ . Effect of charge ratio on lipoplex-mediated gene delivery and liver toxicity . Ther. Del.6 ( 11 ), 1243 – 1253 ( 2015 ).
   PubMedGoogle Scholar
• Betker JL Anchordoquy TJ . Nonadditive effects of repetitive administration of lipoplexes in immunocompetent mice . J. Pharm. Sci.106 ( 3 ), 872 – 881 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Harvie P Wong FMP Bally MB . Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid–DNA particles . J. Pharm. Sci.89 ( 5 ), 652 – 663 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Ishida T Ichihara M Wang X et al. Injection of pegylated liposomes in rats elicits PEG-specific IGM, which is responsible for rapid elimination of a second dose of pegylated liposomes . J. Control. Rel.112 ( 1 ), 15 – 25 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Saadati R Dadashzadeh S Abbasian Z Soleimanjahi H . Accelerated blood clearance of pegylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug . Pharm. Res.-Dordr.30 ( 4 ), 985 – 995 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wang X Ishida T Kiwada H . Anti-PEG IGM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of pegylated liposomes . J. Control. Rel.119 ( 2 ), 236 – 244 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Moghimi SM Farhangrazi ZS . Just so stories: the random acts of anti-cancer nanomedicine performance . Nanomedicine10 ( 8 ), 1661 – 1666 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sabnani MK Rajan R Rowland B et al. Liposome promotion of tumor growth is associated with angiogenesis and inhibition of antitumor immune responses . Nanomedicine11 ( 2 ), 259 – 262 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Shen JN Meng QS Sui HP et al. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shrna for the reversal of lung cancer resistance . Mol. Pharm.11 ( 8 ), 2579 – 2591 ( 2014 ).
   PubMedGoogle Scholar
• Enkvist E Lavogina D Raidaru G et al. Conjugation of adenosine and hexa-(d-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases . J. Med. Chem.49 ( 24 ), 7150 – 7159 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Silva AKA Richard C Ducouret G Bessodes M Scherman D Merten OW . Xyloglucan-derivatized films for the culture of adherent cells and their thermocontrolled detachment: a promising alternative to cells sensitive to protease treatment . Biomacromolecules14 ( 2 ), 512 – 519 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Allen TM Austin GA Chonn A Lin L Lee KC . Uptake of liposomes by cultured mouse bone-marrow macrophages - influence of liposome composition and size . Biochim. Biophys. Acta1061 ( 1 ), 56 – 64 ( 1991 ).
   PubMedGoogle Scholar
• Litzinger DC Buiting AMJ Vanrooijen N Huang L . Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes . Biochim. Biophys. Acta1190 ( 1 ), 99 – 107 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Liu DX Mori A Huang L . Role of liposome size and res blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes . Biochim. Biophys. Acta1104 ( 1 ), 95 – 101 ( 1992 ).
   PubMedGoogle Scholar
• Ross PC Hui SW . Lipoplex size is a major determinant of in vitro lipofection efficiency . Gene Ther.6 ( 4 ), 651 – 659 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Nichols JW Bae YH . EPR: evidence and fallacy . J. Control. Rel.190 , 451 – 464 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Semple SC Chonn A Cullis PR . Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo . Adv. Drug Del. Rev.32 ( 1–2 ), 3 – 17 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Yang JP Huang L . Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA . Gene Ther.4 ( 9 ), 950 – 960 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Zelphati O Uyechi LS Barron LG Szoka FC Jr . Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells . Biochim. Biophys. Acta1390 ( 2 ), 119 – 133 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Betker JL Gomez J Anchordoquy TJ . The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency . J. Control. Rel.171 ( 3 ), 261 – 268 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Crook K Stevenson BJ Dubouchet M Porteous DJ . Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum . Gene Ther.5 ( 1 ), 137 – 143 ( 1998 ).
   PubMed Web of Science ®Google Scholar